Medline (FRA:L10) Other Current Payables: €0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:L10 Medline Inc FRA:L10
16 GF Score
Price €29.80
! 3 Warning Signs
View Full Analysis

What is Medline Other Current Payables?

Medline FRA:L10 +4.20% 16 Other Current Payables is €0 Mil as of Jun. 2026. GuruFocus rates FRA:L10 with a GF Score™ of 16/100. The stock has 3 warning signs investors should review.

Medline's Other Current Payables for the quarter that ended in Jun. 2026 was €0 Mil.

Medline's quarterly Other Current Payables stayed the same from Dec. 2025 (€0 Mil) to Mar. 2026 (€0 Mil) but then declined from Mar. 2026 (€0 Mil) to Jun. 2026 (€0 Mil).

Medline's annual Other Current Payables stayed the same from Dec. 2023 (€0 Mil) to Dec. 2024 (€0 Mil) but then increased from Dec. 2024 (€0 Mil) to Dec. 2025 (€0 Mil).

Medline Other Current Payables Related Terms

Medline Other Current Payables Historical Data

* Premium members only.

The historical data trend for Medline's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medline Other Current Payables Chart

Medline Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Other Current Payables
0.00 0.00 0.00 0.00

Medline Quarterly Data
Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 0.00 0.00 0.00
FRA:L10
16GF Score
Medline Inc FRA:L10
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medline Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of €0 Mil mean?
Medline (FRA:L10) has a Other Current Payables of €0 Mil as of Jun. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Medline and its competitors.
Is Medline's Other Current Payables too high?
Medline's current Other Current Payables is €0 Mil. Overall, Medline has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Medline's Other Current Payables compare to RMD and WST?
Medline's Other Current Payables of €0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Medline and its competitors. Medline's current Other Current Payables is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medline stock overvalued right now?
Medline (FRA:L10) has a current Other Current Payables of €0 Mil. The current Other Current Payables is €0 Mil. Medline's overall GF Score™ is 16/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Medline (FRA:L10), the current Other Current Payables is €0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medline Business Description

Other Exchanges MDLN:USA
Address 3 Lakes Drive, Northfield, IL, USA, 60093
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
16GF Score

Get the complete analysis for FRA:L10

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€29.80
Price